FTC challenges 100 patent listings, tightening screws on pharma companies
The commission recently vowed to take action on alleged anticompetitive IP tactics
To read more
Register for limited access
Register to receive our newsletter and gain limited access to subscriber content.
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the IAM experts.